Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial
about
Role of interleukin-12 gene polymorphisms in the onset risk of cancer: a meta-analysis.Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.ERβ regulation of NF-kB activation in prostate cancer is mediated by HIF-1Impact of Candidate Genetic Polymorphisms in Prostate Cancer: An Overview.The role of IL-23 and the IL-23/TH 17 immune axis in the pathogenesis and treatment of psoriasis.Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.The impact of interleukin-10 (IL-10) gene 4 polymorphisms on peripheral blood IL-10 variation and prostate cancer risk based on published studies.Meta-analysis of the role of IL-6 rs1800795 polymorphism in the susceptibility to prostate cancer: Evidence based on 17 studies.Interleukin 10 gene rs1800896 polymorphism is associated with the risk of prostate cancer.Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial.Association of a common genetic variant in RNASEL and prostate cancer susceptibility.Comprehensive assessment of association between TLR4 gene polymorphisms and cancer risk: a systematic meta-analysis.Associations of IL-10 genetic polymorphisms with the risk of urologic cancer: a meta-analysis based on 18,415 subjects.
P2860
Q33728151-F1DFA77E-366A-4427-AF30-5DB237F03F76Q36827156-71C9E2B8-5302-4007-8DF9-4388B0FD095FQ38261816-1F663AA1-8E0F-42EA-8FE5-125D08064850Q38620751-E724A0EC-4E6C-47B1-B3EC-0DB75B5CE950Q38707588-AEE49ADE-E51D-4975-B8D5-FED82D8E3995Q39368655-9115048A-170D-4A67-B5A4-0A9E4B8EA116Q40286042-4A7E5A5F-C128-495E-A356-9401B8608E9EQ41233882-1456DEAB-77D2-4F2E-A929-E92412F1B39DQ42293538-363CF0FB-74B0-4479-9874-CA7011C3A108Q42371621-03F130C9-1E94-461D-9AE6-CA1CC31958D8Q46314579-E6EB4655-66A0-4248-912C-7120AC866EFEQ46949052-73C703EE-3498-418C-8B7A-C7FD490666A5Q47140213-4775CF46-6E69-4248-A778-02CF38047F99Q50308693-669CBC0F-B84A-4682-8C9B-4375AC3832F5
P2860
Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Variation in genes involved in ...... ostate Cancer Prevention Trial
@ast
Variation in genes involved in ...... ostate Cancer Prevention Trial
@en
type
label
Variation in genes involved in ...... ostate Cancer Prevention Trial
@ast
Variation in genes involved in ...... ostate Cancer Prevention Trial
@en
prefLabel
Variation in genes involved in ...... ostate Cancer Prevention Trial
@ast
Variation in genes involved in ...... ostate Cancer Prevention Trial
@en
P2093
P2860
P356
P1433
P1476
Variation in genes involved in ...... ostate Cancer Prevention Trial
@en
P2093
Angelo M De Marzo
Cathee Till
Catherine M Tangen
Charles G Drake
Danyelle A Winchester
Elizabeth A Platz
Howard L Parnes
Ian M Thompson
M Scott Lucia
Paul J Dluzniewski
P2860
P304
P356
10.1002/PROS.23021
P50
P577
2015-06-05T00:00:00Z